Screener
XBI vs XLV
State Street SPDR S&P Biotech ETF vs State Street Health Care Select Sector SPDR ETF
Key differences
- XLV costs 0.27% less per year.
- XLV is significantly larger than XBI — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XBI has delivered higher annualized returns.
- XLV has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| XBI | XLV | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.08% |
| Fund size (AUM) | $8.3B | $37.9B |
| Since | 2006 | 1998 |
| Dividend yield | 0.34% | 1.72% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +66.6% | +15.9% |
| CAGR 3Y | +15.6% | +6.3% |
| CAGR 5Y | +0.9% | +5.7% |
| Sharpe 3Y | 0.54 | 0.26 |
| Volatility 1Y | 25.14% | 14.55% |
| Max drawdown | -63.89% | -28.40% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XBI and XLV
Explore further